DK0991409T3 - Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse - Google Patents

Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse

Info

Publication number: DK0991409T3
Authority: DK; Denmark
Prior art keywords: hours; controlled release; tiagabine; tenagabine; containing preparations
Prior art date: 1997-08-01

Application number

DK98937738T

Other languages

Danish (da)

English (en)

Inventor

Maurice Joseph Anthony Clancy

Michelle Caulfield

Kenneth Iain Cumming

Original Assignee

Elan Corp Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-01

Filing date

1998-07-30

Publication date

2002-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26320083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0991409(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-08-08 Priority claimed from IE19970588A external-priority patent/IE970588A1/en

1998-07-30 Application filed by Elan Corp Plc filed Critical Elan Corp Plc

2002-03-25 Application granted granted Critical

2002-03-25 Publication of DK0991409T3 publication Critical patent/DK0991409T3/da

Links

238000002360 preparation method Methods 0.000 title abstract 3
238000013270 controlled release Methods 0.000 title abstract 2
230000036470 plasma concentration Effects 0.000 abstract 3
PBJUNZJWGZTSKL-MRXNPFEDSA-N tiagabine Chemical compound C1=CSC(C(=CCCN2C[C@@H](CCC2)C(O)=O)C2=C(C=CS2)C)=C1C PBJUNZJWGZTSKL-MRXNPFEDSA-N 0.000 abstract 3
229960001918 tiagabine Drugs 0.000 abstract 3
239000011159 matrix material Substances 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000008183 oral pharmaceutical preparation Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

DK98937738T 1997-08-01 1998-07-30 Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse DK0991409T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US5443297P	1997-08-01	1997-08-01
IE19970588A IE970588A1 (en)	1997-08-01	1997-08-08	Controlled release pharmaceutical compositions containing tiagabine
PCT/IE1998/000067 WO1999006045A1 (en)	1997-08-01	1998-07-30	Controlled release pharmaceutical compositions containing tiagabine

Publications (1)

Publication Number	Publication Date
DK0991409T3 true DK0991409T3 (da)	2002-03-25

Family

ID=26320083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98937738T DK0991409T3 (da)	1997-08-01	1998-07-30	Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse

Country Status (10)

Country	Link
EP (1)	EP0991409B1 (de)
JP (1)	JP2001511450A (de)
AT (1)	ATE212550T1 (de)
AU (1)	AU8643698A (de)
CA (1)	CA2299464C (de)
DE (1)	DE69803670T2 (de)
DK (1)	DK0991409T3 (de)
ES (1)	ES2172179T3 (de)
PT (1)	PT991409E (de)
WO (1)	WO1999006045A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002325404B2 (en) *	1998-01-22	2006-02-02	Abbott Laboratories	Extended Release Tiagabine Formulations with Reduced Side-effects
ZA99407B (en) *	1998-01-22	1999-07-20	Abbott Lab	Extended release tiagabine formulations with reduced side-effects.
DE60027728T2 (de) *	1999-08-04	2007-04-26	Astellas Pharma Inc.	Stabile medizinische zusammensetzungen zur oralen verabreichung unter verwendung von eisenoxiden
KR100510270B1 (ko) *	2002-11-29	2005-08-26	센츄론(주)	펠렛타이저를 이용한 서방성 제제의 제조방법
US7442387B2 (en) *	2003-03-06	2008-10-28	Astellas Pharma Inc.	Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
CA2518734A1 (en) *	2003-03-14	2004-09-30	Nirmal Mulye	A process for preparing sustained release tablets
US20130143867A1 (en)	2011-12-02	2013-06-06	Sychroneuron Inc.	Acamprosate formulations, methods of using the same, and combinations comprising the same
JP2016520653A (ja)	2013-06-05	2016-07-14	シンクロニューロンインコーポレイテッド	アカンプロサート製剤、それを用いる方法、およびそれを含む合剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK288385D0 (da) *	1985-06-26	1985-06-26	Novo Industri As	Aminosyrederivater
ZA953078B (en) *	1994-04-28	1996-01-05	Alza Corp	Effective therapy for epilepsies
US5750140A (en) *	1994-05-20	1998-05-12	Novo Nordisk A/S	Transdermal delivery of tiagabine
CN1092959C (zh) *	1995-05-05	2002-10-23	诺沃挪第克公司	包含噻加宾或其药学上可接受的盐的药物组合物和其制备方法
DE19525598C2 (de) *	1995-07-13	1997-09-25	Max Planck Gesellschaft	Schlafmittel
ES2297859T3 (es) *	1996-05-24	2008-05-01	Smithkline Beecham Corporation	Uso de inhibidores de la captacion de gaba como agentes antitusivos.
UA52661C2 (uk) *	1996-06-14	2003-01-15	Ново Нордіск А/С	Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) *	1996-07-31	1999-06-22	Novo Nordisk A/S	Treatment of psychotic disorders

1998
- 1998-07-30 PT PT98937738T patent/PT991409E/pt unknown
- 1998-07-30 EP EP98937738A patent/EP0991409B1/de not_active Expired - Lifetime
- 1998-07-30 WO PCT/IE1998/000067 patent/WO1999006045A1/en not_active Ceased
- 1998-07-30 ES ES98937738T patent/ES2172179T3/es not_active Expired - Lifetime
- 1998-07-30 AU AU86436/98A patent/AU8643698A/en not_active Abandoned
- 1998-07-30 DK DK98937738T patent/DK0991409T3/da active
- 1998-07-30 CA CA002299464A patent/CA2299464C/en not_active Expired - Fee Related
- 1998-07-30 DE DE69803670T patent/DE69803670T2/de not_active Expired - Lifetime
- 1998-07-30 JP JP2000504859A patent/JP2001511450A/ja active Pending
- 1998-07-30 AT AT98937738T patent/ATE212550T1/de active

Also Published As

Publication number	Publication date
EP0991409A1 (de)	2000-04-12
DE69803670T2 (de)	2002-11-21
EP0991409B1 (de)	2002-01-30
AU8643698A (en)	1999-02-22
DE69803670D1 (de)	2002-03-14
JP2001511450A (ja)	2001-08-14
CA2299464C (en)	2009-02-17
CA2299464A1 (en)	1999-02-11
ATE212550T1 (de)	2002-02-15
WO1999006045A1 (en)	1999-02-11
ES2172179T3 (es)	2002-09-16
PT991409E (pt)	2002-06-28

Similar Documents

Publication	Publication Date	Title
DK0688214T3 (da)	2000-10-09	Fremgangsmåder til inhibering af knogletab med 3,4-diarylchroman
BR0014383A (pt)	2002-10-22	Composições de liberação controlada compreendendo nimesulida
ATE424810T1 (de)	2009-03-15	Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
CO5251419A1 (es)	2003-02-28	Composiciones nanoparticuladas de eplerenona
MY115662A (en)	2003-08-30	Novel compounds with analgesic effect
GEP20043161B (en)	2004-01-26	Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
BRPI0108977B8 (pt)	2021-05-25	compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
TR200100931T2 (tr)	2001-10-22	Yeni sürekli salınımlı oral formülasyonlar
BR9510168A (pt)	1997-10-14	Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
AP1637A (en)	2006-07-17	Celecoxib compositions.
EP1428821A8 (de)	2005-01-26	Piperidin-4-ylamine mit analgetischer Wirksamkeit
WO2002038171A3 (en)	2003-04-24	METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
YU49202A (sh)	2006-01-16	Benzazolski derivati i njihova upotreba kao modulatora jnk
WO2000001376A3 (en)	2001-03-22	Pharmaceutical compositions and their uses for treatment of demyelinating disorders
EE04606B1 (et)	2006-04-17	H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
ATE305473T1 (de)	2005-10-15	Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
BR0013719A (pt)	2002-07-23	Dosagem oral de liberaçâo controlada, apropriada para administração oral
PT991409E (pt)	2002-06-28	Composicoes farmaceuticas de libertacao controlada contendo tiagabina
DE60202590D1 (de)	2005-02-17	2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO982863L (no)	1998-06-19	Nye forbindelser med analgetisk effekt
BG103512A (en)	2000-07-31	Substituted pyramidine compounds and their application
BR0011880A (pt)	2002-03-19	Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica
ATE275953T1 (de)	2004-10-15	2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
BRPI0415546A (pt)	2006-12-26	composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios